|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0003593,
umls-concept:C0030705,
umls-concept:C0085201,
umls-concept:C0286651,
umls-concept:C0392756,
umls-concept:C0456603,
umls-concept:C0948089,
umls-concept:C0965129,
umls-concept:C1274040,
umls-concept:C1707455,
umls-concept:C2603343
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2010-4-26
|
|
pubmed:databankReference |
|
|
pubmed:abstractText |
The mechanism underlying statin-induced event reduction in patients with acute coronary syndrome remains unclear.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Apolipoprotein A-I,
http://linkedlifedata.com/resource/pubmed/chemical/Apolipoproteins B,
http://linkedlifedata.com/resource/pubmed/chemical/Cholesterol, LDL,
http://linkedlifedata.com/resource/pubmed/chemical/Fluorobenzenes,
http://linkedlifedata.com/resource/pubmed/chemical/Heptanoic Acids,
http://linkedlifedata.com/resource/pubmed/chemical/Hydroxymethylglutaryl-CoA...,
http://linkedlifedata.com/resource/pubmed/chemical/Pyrimidines,
http://linkedlifedata.com/resource/pubmed/chemical/Pyrroles,
http://linkedlifedata.com/resource/pubmed/chemical/Sulfonamides,
http://linkedlifedata.com/resource/pubmed/chemical/atorvastatin,
http://linkedlifedata.com/resource/pubmed/chemical/rosuvastatin
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Mar
|
|
pubmed:issn |
1875-2128
|
|
pubmed:author |
pubmed-author:AlonsoJoaquimJ,
pubmed-author:CENTAURUS investigators,
pubmed-author:DemilNacimaN,
pubmed-author:EhaJaanJ,
pubmed-author:LablancheJean-MarcJM,
pubmed-author:LeoneAttilioA,
pubmed-author:LicourMurielM,
pubmed-author:MerkelyBelaB,
pubmed-author:MoraisJoãoJ,
pubmed-author:SantiniMassimoM,
pubmed-author:TardifJean-ClaudeJC
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
103
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
160-9
|
|
pubmed:dateRevised |
2011-4-25
|
|
pubmed:meshHeading |
pubmed-meshheading:20417447-Acute Coronary Syndrome,
pubmed-meshheading:20417447-Aged,
pubmed-meshheading:20417447-Angioplasty, Balloon, Coronary,
pubmed-meshheading:20417447-Apolipoprotein A-I,
pubmed-meshheading:20417447-Apolipoproteins B,
pubmed-meshheading:20417447-Cholesterol, LDL,
pubmed-meshheading:20417447-Female,
pubmed-meshheading:20417447-Fluorobenzenes,
pubmed-meshheading:20417447-Heptanoic Acids,
pubmed-meshheading:20417447-Humans,
pubmed-meshheading:20417447-Hydroxymethylglutaryl-CoA Reductase Inhibitors,
pubmed-meshheading:20417447-Male,
pubmed-meshheading:20417447-Middle Aged,
pubmed-meshheading:20417447-Multicenter Studies as Topic,
pubmed-meshheading:20417447-Pyrimidines,
pubmed-meshheading:20417447-Pyrroles,
pubmed-meshheading:20417447-Sulfonamides,
pubmed-meshheading:20417447-Treatment Outcome
|
|
pubmed:year |
2010
|
|
pubmed:articleTitle |
Comparison of the efficacy of rosuvastatin versus atorvastatin in reducing apolipoprotein B/apolipoprotein A-1 ratio in patients with acute coronary syndrome: results of the CENTAURUS study.
|
|
pubmed:affiliation |
CHRU-hôpital cardiologique, boulevard du Pr-Jules-Leclercq, 59037 Lille cedex, France. jmlablanche@chru-lille.fr
|
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|
